Products in Development
The NanOlogy therapeutic platform is composed of patented large surface area microparticles (LSAMs) of pure drug designed for tumor-directed therapy via intratumoral, peritoneal, intravesicular, inhalation, and other routes of local administration.

(LSAM Paclitaxel) for Suspension
Ovarian Cancer (intraperitoneal)
Prostate Cancer (intratumoral)
Pancreatic Cancer (intratumoral)
Pancreatic Mucinous Cysts (intracystic)
Lung Cancer (intratumoral/nodal)
(LSAM Docetaxel) for Suspension
Bladder Cancer (resection bed injection)
Renal Cancer (intratumoral)
(LSAM Paclitaxel) for Nebulized Inhalation
Lung Cancer (inhalation)
(Topical Submicron Particle Paclitaxel Suspended in Anhydrous Base)
Cutaneous Metastases
Actinic Keratosis